NASDAQ:JNCE

Jounce Therapeutics Earning Date

USA |NASDAQ |USD

JNCE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 4, 2021 Sep 2021 $-0.44 $-0.08 $-0.73
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 4, 2021 Sep 2021 $6.48M $25.37M $0.00

Jounce Therapeutics's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 2021.

JNCE Earnings Date & History Chart

JNCE Earnings & Revenue Forecast

JNCE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-0.31 $-0.64 $0.59
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-1.41 $-1.87 $-0.65
Dec 2022 8 $-2.01 $-2.64 $-0.68

JNCE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.30 $-0.30 $-0.32
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.39 $-1.39 $-1.80
Dec 2022 0 / 0 $-2.00 $-2.00 $-2.02

JNCE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $12.19M $0.00 $55.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $45.71M $26.90M $83.00M
Dec 2022 8 $19.20M $0.00 $83.60M

JNCE Earnings Date & Revenue History

JNCE Earnings History

|
Show More
Show More

JNCE Revenue History

|
Show More
Show More

Jounce Therapeutics Next Earnings Date & Report

JNCE Next Earnings Date & Report Preview: Sep 2021 (FQ)

JNCE's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Jounce Therapeutics's next quarterly earnings is $-0.44, with a low EPS estimation of $-0.59, and a high estimation of $-0.02.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.44, the last 2 month trend is $-0.44, and the 3 month trend is $-0.54.

Based on 8 analysts, the average revenue estimation is $6.48M, with a low revenue estimation of $0.00, and a high estimation of $25.37M.

Jounce Therapeutics Previous Earnings Dates & Reports

JNCE Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Jounce Therapeutics's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

JNCE's earnings per share (EPS) was $-0.08, beating the consensus analysts forecast of $-0.33 by 75.60%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -86.21%, and higher than the same period a year before (Jun 2020) by -90.24%.

Revenues were $25.37M.

The company reported a net income of $-4.01M.

Free cash flow for the quarter was $-24.91M , compared to $-33.71M last quarter and $-21.43M a year before.

JNCE ended the quarter with $15.34M in total debt, a decrease of -5.06% compared to the previous quarter, and a decrease of -16.56% compared to the same quarter a year before.

JNCE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Jounce Therapeutics's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

JNCE's earnings per share (EPS) was $-1.47, beating the consensus analysts forecast of $-1.99 by -26.13% , and lower than the previous year's EPS (Dec 2019) by -190.18%.

Revenues were $62.34M, better than the forecast of $33.66M by 85.20%, and down by -57.84% from previous year's revenue.

The company reported a net income of $-43.84M.

Jounce Therapeutics reported a free cash flow of $-27.88M for its fiscal year, compared to $-31.11M a year ago.

The company ended the fiscal year with $16.89M in total debt, a decrease of -14.66% compared to the previous year.